Table 3.
RF | n | Sensitivity (%) | Specificity (%) | PPV (%) | Used for staging | Reference |
---|---|---|---|---|---|---|
18F-FDG | 78 | 56 | 98 | NA | Y | [5,60] |
18F-FDG | 54 | 41 | 86 | 58 | Y | [5,63] |
18F-FDG | 61 | 47.1 | 93.2 | 72.7 | Y | [5,68] |
18F-FDG | 93 | 68 | 95 | 86 | Y | [5,69] |
11C-Choline | 26 | 42 | 84 | 50 | Y | [69,72] |
11C-Choline | 59 | 59 | 90 | 71 | Y | [69,73] |
Note– RF= Radiopharmaceutical, n= Patient number, NA= Not applicable, PPV: Positive Predictive Value, 18F-FDG= 18Fluorine-2-deoxy-2-fluorodeoxyglucose, 11C= 11Carbon, Y: Yes